Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)
- Status
- COMPLETED
- Phase
- PHASE1
MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)
- Status
- COMPLETED
- Phase
- PHASE2
PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b
- Status
- UNKNOWN
- Phase
- PHASE3
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668)
- Status
- WITHDRAWN
- Phase
- PHASE2
Impact of Hepatitis C Therapy and Bone Health
- Status
- TERMINATED
- Phase
- PHASE4
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
- Status
- RECRUITING
- Phase
- PHASE1
A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014)
- Status
- COMPLETED
- Phase
- PHASE1
MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- Status
- RECRUITING
- Phase
- PHASE3
Perceptual-Cognitive Training After a Mild Traumatic Brain Injury: Towards a Sensitive Marker for Recovery
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2